| Kathleen Fay, | |
|
55 Arch St Ste 3a, Akron, OH 44304-1447 | |
| (330) 375-3584 | |
| (330) 375-3730 |
| Full Name | Kathleen Fay |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 55 Arch St Ste 3a, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427554096 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35.141881 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome.
Biodel Inc. today announced the initiation of a Phase 2 clinical trial of its proprietary recombinant insulin (RHI)-based ultra-rapid-acting mealtime insulin candidate, BIOD-123.
Pfizer Inc. announced today that top-line results for Lyrica (pregabalin) capsules Study A0081147 - Long Term Safety and Efficacy of Pregabalin in Subjects with Generalized Anxiety Disorder (GAD) - demonstrate that drug discontinuation symptoms were low after tapering Lyrica treatment following three months and six months in GAD patients.
The wisest course now is to replace the new health care law with immediate insurance reforms and step-by-step reductions in health care costs so that more Americans can afford to buy insurance (Sen. Lamar Alexander, 4/3).
› Verified 5 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome.
Biodel Inc. today announced the initiation of a Phase 2 clinical trial of its proprietary recombinant insulin (RHI)-based ultra-rapid-acting mealtime insulin candidate, BIOD-123.
Pfizer Inc. announced today that top-line results for Lyrica (pregabalin) capsules Study A0081147 - Long Term Safety and Efficacy of Pregabalin in Subjects with Generalized Anxiety Disorder (GAD) - demonstrate that drug discontinuation symptoms were low after tapering Lyrica treatment following three months and six months in GAD patients.
The wisest course now is to replace the new health care law with immediate insurance reforms and step-by-step reductions in health care costs so that more Americans can afford to buy insurance (Sen. Lamar Alexander, 4/3).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Fay, 525 E. Market St., Akron, OH 44304 Ph: (330) 375-3584 | Kathleen Fay, 55 Arch St Ste 3a, Akron, OH 44304-1447 Ph: (330) 375-3584 |
News Archive
UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome.
Biodel Inc. today announced the initiation of a Phase 2 clinical trial of its proprietary recombinant insulin (RHI)-based ultra-rapid-acting mealtime insulin candidate, BIOD-123.
Pfizer Inc. announced today that top-line results for Lyrica (pregabalin) capsules Study A0081147 - Long Term Safety and Efficacy of Pregabalin in Subjects with Generalized Anxiety Disorder (GAD) - demonstrate that drug discontinuation symptoms were low after tapering Lyrica treatment following three months and six months in GAD patients.
The wisest course now is to replace the new health care law with immediate insurance reforms and step-by-step reductions in health care costs so that more Americans can afford to buy insurance (Sen. Lamar Alexander, 4/3).
› Verified 5 days ago
Leon L. Zhong, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-4000 | |
Dr. Adarsh E Krishen, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 444 W Exchange St, Akron, OH 44302 Phone: 234-417-7630 | |
Dr. Lynn M Hamrich, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Arch St Ste 3a, Akron, OH 44304 Phone: 330-375-3584 Fax: 234-312-2307 | |
James Jude Brown, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 5147 Manchester Rd, Akron, OH 44319 Phone: 330-644-3747 Fax: 330-644-9815 | |
Mr. William Kevin Lonsdorf, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2818 S Arlington Rd, Akron, OH 44312 Phone: 330-645-0148 Fax: 330-645-1524 | |
Trisha Imhoff, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Arch St, Suite 3a, Akron, OH 44304 Phone: 330-375-3584 | |
Dr. Cynthia Link Weinstein, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 N Cleveland Massillon Rd, Suite 203, Akron, OH 44333 Phone: 330-666-9769 Fax: 330-666-7530 |